Zevra Reports Positive Phase 2 Results for Idiopathic Hypersomnia Drug Candidate
The positive top-line results of the phase 2 trial support the safety and tolerability of KP1077.
The positive top-line results of the phase 2 trial support the safety and tolerability of KP1077.